Author name: Claritas Rx

white paper available: One Month to $241K: Real-Time Market Access Insights Deliver Measurable Gains

One Month to $241K: Real-Time Market Access Insights Deliver Measurable Gains

White Papers

Accelerating market access data delivery from multi-day lags to next-day reporting enables earlier patient interventions, reduces therapy abandonment, and can potentially deliver over $241K in measurable revenue gains in one month. A single-day improvement in data availability supported faster therapy starts for hundreds of patients, prevented drop-offs, and freed teams to focus on strategic initiatives […]

One Month to $241K: Real-Time Market Access Insights Deliver Measurable Gains Read More »

case study - doctor checking patient with stetoscope

Claritas Rx Ascend® Platform Case Study: Improving Liver Disease Patient Outcomes

Case Studies

A case study on Claritas Rx’s Ascend® Platform offers a compelling look at how technology-driven intervention strategies can drive better outcomes for liver disease patients. A mid-sized U.S. pharmaceutical company partnered with Claritas Rx to tackle persistent challenges in patient conversions and medication adherence—key hurdles often exacerbated by lengthy prescription processing times and medication stock-outs. 

Claritas Rx Ascend® Platform Case Study: Improving Liver Disease Patient Outcomes Read More »

Claritas Rx's Access Analytics live webinar September 25 at 1 pm et

Data-Driven Revenue Strategies: The Role of Real-Time Market Access Insights in Achieving $241K in One Month

Webinars

Watch the Recording Join our upcoming webinar, designed for market access and patient support leaders, to address the real-world challenges of fragmented data and operational roadblocks that delay therapy initiation and impact revenue. This session will highlight how real-time, integrated data is transforming patient journeys by accelerating access, reducing abandonment, and delivering measurable business benefits.

Data-Driven Revenue Strategies: The Role of Real-Time Market Access Insights in Achieving $241K in One Month Read More »

Access Analytics news release

Claritas Rx Access Analytics Delivers Real-Time Visibility Into Biopharma Brand Performance

News

Real-Time Channel Intelligence Empowers Smarter Market Access and Better Patient Outcomes New Thought Leadership Entitled “One Month to $241K: Real-Time Market Access Insights Deliver Measurable Gains” Now Available September 8, 2025 – SOUTH SAN FRANCISCO, CA – Claritas Rx, the patient journey experts, announced the availability of Access Analytics that delivers real-time channel and competitive

Claritas Rx Access Analytics Delivers Real-Time Visibility Into Biopharma Brand Performance Read More »

Reinventing Payer Mastering : A Thought Leadership Perspective

Reinventing Payer Mastering: A Thought Leadership Perspective

Blog

Author: Meghna Misra, Head of Product at Claritas Rx In the rapidly evolving life sciences industry, the complexities of the U.S. healthcare system create significant challenges for market access, analytics, and patient outcomes. Central to overcoming these challenges is payer mastering, an advanced capability that, when applied strategically, enables organizations to move beyond incremental progress

Reinventing Payer Mastering: A Thought Leadership Perspective Read More »

Claritas Rx Ascend® Platform Case Study: Faster Actions, Higher Fills, and $30M+ Therapy Value

Case Studies

A Claritas Rx case study showcases the transformative power of the company’s Ascend® Platform in supporting patient access, faster actions, and quantifiable financial impact for specialty therapies. A mid-sized U.S. pharmaceutical brand relied on the platform to boost patient conversions and adherence for an oral oncology drug, targeting longstanding challenges with delayed processing and refill

Claritas Rx Ascend® Platform Case Study: Faster Actions, Higher Fills, and $30M+ Therapy Value Read More »

Claritas Rx Named to the 2025 Inc. 5000 List, Ranking Among America’s Fastest-Growing Private Companies

Claritas Rx Named to the 2025 Inc. 5000 List, Ranking Among America’s Fastest-Growing Private Companies

News

South San Francisco, CA, August 12, 2025 – Claritas Rx, the leader in intelligent solutions that provide real-time visibility across the entire patient journey, announced today it has been named to the prestigious Inc. 5000 list, the most respected ranking of the fastest-growing private companies in America. The list provides a data-driven snapshot of the most

Claritas Rx Named to the 2025 Inc. 5000 List, Ranking Among America’s Fastest-Growing Private Companies Read More »

Claritas Rx Offers Four Strategies to Mitigate Specialty Treatment Abandonment

Claritas Rx Offers Four Strategies to Mitigate Specialty Treatment Abandonment

News

New White Paper Entitled “From Prescription to Abandonment: How 31% of Specialty Medications Go Unfilled Across Therapeutic Areas” Now Available South San Francisco, CA, July 28, 2025 – Claritas Rx, the leader in technology and analytics to optimize the specialty patient experience, announces the availability of its new white paper entitled “From Prescription to Abandonment:

Claritas Rx Offers Four Strategies to Mitigate Specialty Treatment Abandonment Read More »

Patient Support Services Congress panel information

Join us at the PSS Congress on November 21 for a dynamic panel exploring how patient support strategies evolve across pharma companies of all sizes—from startups to enterprises

Events

Scaling Patient Support – Navigating Challenges and Opportunities Across Organization Size and Stage Join industry leaders for an insightful panel discussion exploring the nuances of patient support programs across large, mid-size and small pharmaceutical companies. This session will delve into the unique challenges, opportunities and best practices for each company size, providing valuable benchmarking insights

Join us at the PSS Congress on November 21 for a dynamic panel exploring how patient support strategies evolve across pharma companies of all sizes—from startups to enterprises Read More »